Navigation Links
BioCryst to Present at Oppenheimer Healthcare Conference
Date:10/29/2009

BIRMINGHAM, Ala., Oct. 29 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Jon P. Stonehouse, President and Chief Executive Officer of BioCryst, and Stuart Grant, Chief Financial Officer of BioCryst, plan to provide a corporate summary at the Oppenheimer & Co., Inc. 20th Annual Healthcare Conference in New York on Wednesday, November 4, 2009 at 1:35 p.m. Eastern Time.

Links to a live audio Web cast and replay of the presentation may be accessed on the BioCryst Web site at www.biocryst.com.

About BioCryst

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory diseases. BioCryst has progressed two novel compounds into late-stage pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a purine nucleoside phosphorylase (PNP) inhibitor for cutaneous T-cell lymphoma (CTCL). Utilizing crystallography and structure-based drug design, BioCryst continues to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. The Company's strategic alliances with the U.S. Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross Corporation and Mundipharma International Holdings Limited validate its scientific foundation and the utility of its product candidates. For more information, please visit the Company's Web site at www.biocryst.com.

This press release contains forward-looking statements, including statements regarding future results and achievements. These statements involve known and unknown risks, uncertainties
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Emergency Use Authorization Granted For BioCrysts Peramivir
2. BioCryst to Present at JMP Securities Healthcare Conference
3. BioCryst Clarifies Government Declaration Regarding Peramivir
4. BioCryst Provides Update Regarding Peramivir for Influenza
5. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
6. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
7. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
8. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
9. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
10. BioCryst Updates Peramivir Clinical Development Plan
11. BioCryst Provides Forodesine HCl Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... NEW YORK , Sept. 17, 2014 /PRNewswire/ ... Summary GlobalData,s new report, "Germany ... market data on the Germany Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ...
(Date:9/17/2014)... Sept. 17, 2014  Dr. Stephen Loyd , ... House today for National Recovery Month, stars in a ... released today. Consumer advocates were also joined by a ... out after losing her fiancée because of a preventable ... had a history of crack cocaine abuse. Proposition 46 ...
(Date:9/17/2014)... , Sept. 17, 2014  Decision Resources ... (CD/UC) patients eligible for biologic therapy, only ... biologic. Surveyed gastroenterologists cite patients, discomfort with ... low penetration rates, followed by cost-related issues ... patients receiving biologics, Janssen Biotech,s Remicade and ...
Breaking Medicine Technology:Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 2Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 3The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3
(Date:9/17/2014)... September 17, 2014 Sunday night ... Kazantsev and ushered in a new national spokesperson ... Miss America Organization’s official national platform, Children’s ... its newest National Goodwill Ambassador. , Kazantsev’s year ... Miracle Network Hospitals across the U.S., visiting with ...
(Date:9/17/2014)... be preventable with a vaccine, new research in mice ... Washington University School of Medicine in St. Louis, prevented ... in hospitals and other care facilities to drain urine ... catheter is present in the urethra and the bladder, ... patient who has a catheter for more than 30 ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 People who struggle ... now head to http://www.perwickstrom.com and get the answer ... thing to point out, is that a business plan and ... they work together, commented Per Wickstrom. “The way I view ... by a business strategy which is part two.” , ...
(Date:9/17/2014)... to the ends of chromosomes could hold the key to ... of skin cancer according to new research from the ... important new genetic risk factor for melanoma. , It is ... indicators of those most at risk of developing melanoma. For ... as they burn more easily. , It now appears that ...
(Date:9/17/2014)... Dallas, TX (PRWEB) September 17, 2014 ... they were recently granted several awards for their top-notch ... regarding patient experience, orthopedic care and GYN surgery. , ... Patient Safety Excellence Award™. They have received this award ... ranked among the top 5 percent in the nation ...
Breaking Medicine News(10 mins):Health News:Miss America 2015 Kira Kazantsev Takes On Role as Children’s Miracle Network Hospitals National Goodwill Ambassador 2Health News:Miss America 2015 Kira Kazantsev Takes On Role as Children’s Miracle Network Hospitals National Goodwill Ambassador 3Health News:In mice, vaccine stops urinary tract infections linked to catheters 2Health News:In mice, vaccine stops urinary tract infections linked to catheters 3Health News:Per Wickstrom’s Latest Blog Explores the Difference Between a Business Plan and a Business Strategy 2Health News:Chromosome buffers hold key to better melanoma understanding 2Health News:North Central Surgical Center Receives Several Accolades 2
... In a first-of-its-kind clinical trial, physician-scientists at University ... method to potentially prevent recurrence of an early stage, ... conducted by Joe Baar, MD, Director of Breast Cancer ... is recruiting patients with HER-2 neu+ breast cancer. ...
... Spanish and French . , The ... among Muslim adolescents than among their Christian classmates. Similarly, body ... a general conclusion, an average of one in four adolescents ... dissatisfaction. These were the conclusions drawn of a research conducted ...
... the latest issue of Deutsches rzteblatt International ... Hensel,s research group presents epidemiological data. The authors ... centers specializing in the treatment of HIV patients in ... able to analyze the largest collection of data on ...
... field for analysis of low molecular weight compounds in ... metabolite level changes in biological samples. Recently, metabolomic method ... markers and therapeutic targets for cancers. However, metabolomic studies ... to be published on February 14, 2011 in the ...
... venous leg ulcers is good quality nursing care and ... the University of Leeds has shown that ultrasound therapy does ... contrary to what had been expected. Traditional methods of ... just as well, the authors conclude. "The ,healing energy, ...
... 8 (HealthDay News) -- Acupuncture may help reduce the ... according to a small study. The research included ... acupuncture twice a week and the others given sham ... the traditional acupuncture group had significantly less severe hot ...
Cached Medicine News:Health News:Novel clinical trial aims to reduce recurrence of aggressive breast cancer 2Health News:Eating disorders and body dissatisfaction is double in Muslim teenagers than in Christian 2Health News:Laughter really is the best medicine (for leg ulcers) 2
Provides 30% more magnification and twice the field of view. Adjustable focus, with insufflator bulb....
Features a built-in throat illuminator, providing 30% more magnification and twice the field of view. Adjustable focus....
... The Novus Spectra photocoagulator delivers ... in diode-pumped solid-state (DPSS) technology. Diode ... power from the compact Novus Spectra ... ensures stable beam output and system ...
A standard, durable and reliable indirect....
Medicine Products: